Rogers Alberto Ñahui Palomino

Rogers Alberto Ñahui Palomino

Auto-generated profile, based on publicly available information

Rogers Alberto Ñahui Palomino

Department of Pharmacy and BioTechnology, University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
RPRogers A. Ñahui Palomino
Rogers A. Ñahui Palomino
CVChristophe Vanpouille
Christophe Vanpouille
PCPaolo Emidio Costantini
Paolo Emidio Costantini
LMLeonid Margolis
Leonid Margolis
Both gram-negative and gram-positive bacteria release extracellular vesicles (EVs) that contain components from their mother cells. Bacterial EVs are similar in size to mammalian-derived EVs and are thought to mediate bacteria–host communications by transporting diverse bioactive molecules including proteins, nucleic acids, lipids, and metabolites. Bacterial EVs have been implicated in bacteria–bacteria and bacteria–host interactions, promoting health or causing various pathologies. Although the science of bacterial EVs is less developed than that of eukaryotic EVs, the number of studies on bacterial EVs is continuously increasing. This review highlights the current state of knowledge in the rapidly evolving field of bacterial EV science, focusing on their discovery, isolation, biogenesis, and more specifically on their role in microbiota–host communications. Knowledge of these mechanisms may be translated into new therapeutics and diagnostics based on bacterial EVs.

22 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Carola ParolinCarola Parolin
Carola Parolin
Antonella MarangoniAntonella Marangoni
Antonella Marangoni
Luca LaghiLuca Laghi
Luca Laghi
Claudio FoschiClaudio Foschi
Claudio Foschi
RPRogers Alberto Ñahui Palomino
Rogers Alberto Ñahui Palomino
Beatrice VitaliBeatrice Vitali
Beatrice Vitali
Healthy vaginal microbiota is dominated by Lactobacillus spp., which form a critical line of defence against pathogens, including Candida spp. The present study aims to identify vaginal lactobacilli exerting in vitro activity against Candida spp. and to characterize their antifungal mechanisms of action. Lactobacillus strains were isolated from vaginal swabs of healthy premenopausal women. The isolates were taxonomically identified to species level (L. crispatus B1-BC8, L. gasseri BC9-BC14 and L. vaginalis BC15-BC17) by sequencing the 16S rRNA genes. All strains produced hydrogen peroxide and lactate. Fungistatic and fungicidal activities against C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis and C. lusitaniae were evaluated by broth micro-dilution method. The broadest spectrum of activity was observed for L. crispatus BC1, BC4, BC5 and L. vaginalis BC15, demonstrating fungicidal activity against all isolates of C. albicans and C. lusitaniae. Metabolic profiles of lactobacilli supernatants were studied by 1H-NMR analysis. Metabolome was found to be correlated with both taxonomy and activity score. Exclusion, competition and displacement experiments were carried out to investigate the interference exerted by lactobacilli toward the yeast adhesion to HeLa cells. Most Lactobacillus strains significantly reduced C. albicans adhesion through all mechanisms. In particular, L. crispatus BC2, L. gasseri BC10 and L. gasseri BC11 appeared to be the most active strains in reducing pathogen adhesion, as their effects were mediated by both cells and supernatants. Inhibition of histone deacetylases was hypothesised to support the antifungal activity of vaginal lactobacilli. Our results are prerequisites for the development of new therapeutic agents based on probiotics for prophylaxis and adjuvant therapy of Candida infection.

29 June 2016 in Scientific Reports
Verified
Journal Article
Open access
PNPaola Nardini
Paola Nardini
RPRogers Alberto Ñahui Palomino
Rogers Alberto Ñahui Palomino
Carola ParolinCarola Parolin
Carola Parolin
Luca LaghiLuca Laghi
Luca Laghi
Claudio FoschiClaudio Foschi
Claudio Foschi
Antonella MarangoniAntonella Marangoni
Antonella Marangoni
Lactobacillus species dominate the vaginal microbiota of healthy reproductive-age women and protect the genitourinary tract from the attack of several infectious agents. Chlamydia trachomatis, a leading cause of sexually transmitted disease worldwide, can induce severe sequelae, i.e. pelvic inflammatory disease, infertility and ectopic pregnancy. In the present study we investigated the interference of Lactobacillus crispatus, L. gasseri and L. vaginalis, known to be dominant species in the vaginal microbiome, with the infection process of C. trachomatis. Lactobacilli exerted a strong inhibitory effect on Chlamydia infectivity mainly through the action of secreted metabolites in a concentration/pH dependent mode. Short contact times were the most effective in the inhibition, suggesting a protective role of lactobacilli in the early steps of Chlamydia infection. The best anti-Chlamydia profile was shown by L. crispatus species. In order to delineate metabolic profiles related to anti-Chlamydia activity, Lactobacillus supernatants were analysed by 1H-NMR. Production of lactate and acidification of the vaginal environment seemed to be crucial for the activity, in addition to the consumption of the carbonate source represented by glucose. The main conclusion of this study is that high concentrations of L. crispatus inhibit infectivity of C. trachomatis in vitro.

11 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RPRogers A. Ñahui Palomino
Rogers A. Ñahui Palomino
CVChristophe Vanpouille
Christophe Vanpouille
Luca LaghiLuca Laghi
Luca Laghi
Carola ParolinCarola Parolin
Carola Parolin
KMKamran Melikov
Kamran Melikov
LMLeonid Margolis
Leonid Margolis
The vaginal microbiota, dominated by Lactobacillus spp., plays a key role in preventing HIV-1 transmission. Here, we investigate whether the anti-HIV effect of lactobacilli is mediated by extracellular vesicles (EVs) released by these bacteria. Human cervico-vaginal and tonsillar tissues ex vivo, and cell lines were infected with HIV-1 and treated with EVs released by lactobacilli isolated from vaginas of healthy women. EVs released by L. crispatus BC3 and L. gasseri BC12 protect tissues ex vivo and isolated cells from HIV-1 infection. This protection is associated with a decrease of viral attachment to target cells and viral entry due to diminished exposure of Env that mediates virus-cell interactions. Inhibition of HIV-1 infection is associated with the presence in EVs of several proteins and metabolites. Our findings demonstrate that the protective effect of Lactobacillus against HIV-1 is, in part, mediated by EVs released by these symbiotic bacteria. If confirmed in vivo, this finding may lead to new strategies to prevent male-to-female sexual HIV-1 transmission.

19 May 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
RPRogers A. Ñahui Palomino
Rogers A. Ñahui Palomino
SZSonia Zicari
Sonia Zicari
Christophe VanpouilleChristophe Vanpouille
Christophe Vanpouille
BVBeatrice Vitali
Beatrice Vitali
LMLeonid Margolis
Leonid Margolis
Lactobacillus species, which dominate vaginal microbiota of healthy reproductive-age women lower the risks of sexually transmitted infections, including the risk of HIV acquisition. The exact mechanisms of this protection remain to be understood. Here, we investigated these mechanisms in the context of human cervico-vaginal and lymphoid tissues ex vivo. We found that all six lactobacilli strains tested in these systems significantly suppressed HIV-1 infection. We identified at least three factors that mediated this suppression. (i) Acidification of the medium. The pH of the undiluted medium conditioned by lactobacilli was between 3.8 and 4.6. Acidification of the culture medium with HCl to this pH in control experiments was sufficient to abrogate HIV-1 replication. However, Lactobacillus-conditioned medium diluted five fold, which reached pH ~ 6.9 was also suppressive for HIV-1 infection while in control experiments HIV-1 infection was not abrogated when the pH of the medium was brought to 6.9 using HCl. This suggested the existence of other factors responsible for HIV-1 inhibition by lactobacilli. (ii) Lactic acid. There was a correlation between the concentration of lactic acid in the Lactobacillus-conditioned medium and its ability to suppress HIV-1 infection in human tissues ex vivo. Addition of lactic acid isomers D and L to tissue culture medium at the concentration that corresponded to their amount released by lactobacilli resulted in HIV-1 inhibition. Isomer L was produced in higher quantities than isomer D and was mostly responsible for HIV-1 inhibition. These results indicate that lactic acid, in particular its L-isomer, inhibit HIV-1 independently of lowering of the pH. (iii) Virucidal effect. Incubation of HIV-1 in Lactobacillus–conditioned medium significantly suppressed viral infectivity for human tissues ex vivo. Finally, lactobacilli adsorb HIV-1 serving as a sink decreasing the amount of free virions. In summary, we found that lactobacilli inhibit HIV-1 replication in human tissue ex vivo by multiple mechanisms. Further studies are needed to evaluate the potential of altering the spectra of vaginal microbiota as effective strategies to enhance vaginal health. Human tissues ex vivo may serve as a test system for these strategies.

1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Teresa CerchiaraTeresa Cerchiara
Teresa Cerchiara
AAAngela Abruzzo
Angela Abruzzo
RPRogers Alberto Ñahui Palomino
Rogers Alberto Ñahui Palomino
BVBeatrice Vitali
Beatrice Vitali
RRRenata De Rose
Renata De Rose
BLBarbara Luppi
Barbara Luppi